Goldman Sachs’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $86.2M | Sell |
685,865
-51,572
| -7% | -$6.48M | 0.01% | 838 |
|
2025
Q1 | $81.6M | Sell |
737,437
-246,362
| -25% | -$27.2M | 0.01% | 776 |
|
2024
Q4 | $134M | Sell |
983,799
-33,355
| -3% | -$4.55M | 0.02% | 551 |
|
2024
Q3 | $117M | Sell |
1,017,154
-115,435
| -10% | -$13.3M | 0.02% | 619 |
|
2024
Q2 | $156M | Buy |
1,132,589
+356,862
| +46% | +$49.1M | 0.03% | 521 |
|
2024
Q1 | $107M | Buy |
775,727
+84,095
| +12% | +$11.6M | 0.02% | 638 |
|
2023
Q4 | $91.1M | Sell |
691,632
-95,323
| -12% | -$12.6M | 0.02% | 705 |
|
2023
Q3 | $88.5M | Sell |
786,955
-37,682
| -5% | -$4.24M | 0.02% | 669 |
|
2023
Q2 | $77.8M | Sell |
824,637
-145,163
| -15% | -$13.7M | 0.02% | 719 |
|
2023
Q1 | $98.2M | Sell |
969,800
-359,922
| -27% | -$36.4M | 0.02% | 614 |
|
2022
Q4 | $159M | Buy |
1,329,722
+127,932
| +11% | +$15.3M | 0.04% | 434 |
|
2022
Q3 | $128M | Sell |
1,201,790
-53,033
| -4% | -$5.63M | 0.03% | 500 |
|
2022
Q2 | $122M | Sell |
1,254,823
-241,629
| -16% | -$23.6M | 0.03% | 521 |
|
2022
Q1 | $140M | Sell |
1,496,452
-28,063
| -2% | -$2.63M | 0.03% | 501 |
|
2021
Q4 | $130M | Buy |
1,524,515
+81,017
| +6% | +$6.9M | 0.03% | 558 |
|
2021
Q3 | $138M | Buy |
1,443,498
+20,210
| +1% | +$1.94M | 0.03% | 496 |
|
2021
Q2 | $139M | Buy |
1,423,288
+15,814
| +1% | +$1.54M | 0.03% | 480 |
|
2021
Q1 | $137M | Buy |
1,407,474
+189,709
| +16% | +$18.4M | 0.03% | 445 |
|
2020
Q4 | $117M | Buy |
1,217,765
+328,594
| +37% | +$31.5M | 0.03% | 464 |
|
2020
Q3 | $85.5M | Sell |
889,171
-55,498
| -6% | -$5.34M | 0.02% | 571 |
|
2020
Q2 | $115M | Buy |
944,669
+42,587
| +5% | +$5.2M | 0.04% | 453 |
|
2020
Q1 | $78.1M | Buy |
902,082
+242,342
| +37% | +$21M | 0.03% | 560 |
|
2019
Q4 | $70.9M | Sell |
659,740
-8,347
| -1% | -$897K | 0.02% | 820 |
|
2019
Q3 | $60.2M | Buy |
668,087
+95,698
| +17% | +$8.62M | 0.02% | 883 |
|
2019
Q2 | $48.3M | Buy |
572,389
+37,857
| +7% | +$3.2M | 0.01% | 1040 |
|
2019
Q1 | $47.1M | Sell |
534,532
-43,115
| -7% | -$3.8M | 0.01% | 1052 |
|
2018
Q4 | $41.3M | Sell |
577,647
-733,011
| -56% | -$52.3M | 0.01% | 1076 |
|
2018
Q3 | $161M | Sell |
1,310,658
-128,782
| -9% | -$15.8M | 0.04% | 453 |
|
2018
Q2 | $141M | Sell |
1,439,440
-341,934
| -19% | -$33.6M | 0.04% | 507 |
|
2018
Q1 | $148M | Sell |
1,781,374
-351,821
| -16% | -$29.2M | 0.04% | 524 |
|
2017
Q4 | $166M | Sell |
2,133,195
-305,162
| -13% | -$23.7M | 0.04% | 475 |
|
2017
Q3 | $149M | Sell |
2,438,357
-235,860
| -9% | -$14.5M | 0.04% | 493 |
|
2017
Q2 | $123M | Buy |
2,674,217
+930,268
| +53% | +$42.8M | 0.03% | 561 |
|
2017
Q1 | $75.5M | Buy |
1,743,949
+997,434
| +134% | +$43.2M | 0.02% | 796 |
|
2016
Q4 | $28.9M | Buy |
746,515
+24,619
| +3% | +$953K | 0.01% | 1298 |
|
2016
Q3 | $36.6M | Buy |
721,896
+81,257
| +13% | +$4.11M | 0.01% | 1146 |
|
2016
Q2 | $29.1M | Sell |
640,639
-142,600
| -18% | -$6.48M | 0.01% | 1195 |
|
2016
Q1 | $31M | Buy |
783,239
+574,102
| +275% | +$22.7M | 0.01% | 1148 |
|
2015
Q4 | $11.8M | Sell |
209,137
-112,837
| -35% | -$6.38M | ﹤0.01% | 1597 |
|
2015
Q3 | $12.8M | Buy |
321,974
+87,128
| +37% | +$3.47M | ﹤0.01% | 1517 |
|
2015
Q2 | $11.2M | Sell |
234,846
-333,762
| -59% | -$15.9M | ﹤0.01% | 1635 |
|
2015
Q1 | $22.6M | Buy |
568,608
+154,995
| +37% | +$6.15M | 0.01% | 1252 |
|
2014
Q4 | $9.24M | Sell |
413,613
-203,819
| -33% | -$4.55M | ﹤0.01% | 1649 |
|
2014
Q3 | $9.68M | Sell |
617,432
-4,647
| -0.7% | -$72.8K | ﹤0.01% | 1624 |
|
2014
Q2 | $9.23M | Sell |
622,079
-119,491
| -16% | -$1.77M | ﹤0.01% | 1654 |
|
2014
Q1 | $11.9M | Buy |
741,570
+321,720
| +77% | +$5.18M | ﹤0.01% | 1500 |
|
2013
Q4 | $3.92M | Sell |
419,850
-120,142
| -22% | -$1.12M | ﹤0.01% | 2170 |
|
2013
Q3 | $6.11M | Buy |
539,992
+187,314
| +53% | +$2.12M | ﹤0.01% | 1771 |
|
2013
Q2 | $4.72M | Buy |
+352,678
| New | +$4.72M | ﹤0.01% | 1808 |
|